

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of activation of Janus kinase activity (GO:0010533) | 9.37926611 |
| 2 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 9.26272300 |
| 3 | cellular anion homeostasis (GO:0030002) | 8.04328223 |
| 4 | positive regulation of cell fate commitment (GO:0010455) | 7.98076583 |
| 5 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 7.90723078 |
| 6 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 7.19104865 |
| 7 | positive regulation of activated T cell proliferation (GO:0042104) | 7.05766859 |
| 8 | positive regulation of interleukin-17 production (GO:0032740) | 6.73191760 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.60496549 |
| 10 | cellular response to gamma radiation (GO:0071480) | 5.96462028 |
| 11 | regulation of memory T cell differentiation (GO:0043380) | 5.94312357 |
| 12 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 5.67791891 |
| 13 | cell migration involved in gastrulation (GO:0042074) | 5.58158126 |
| 14 | secondary heart field specification (GO:0003139) | 5.26289927 |
| 15 | heart field specification (GO:0003128) | 5.26289927 |
| 16 | cell migration involved in heart development (GO:0060973) | 5.15777400 |
| 17 | DNA deamination (GO:0045006) | 5.08826719 |
| 18 | negative regulation of cell fate specification (GO:0009996) | 5.04857170 |
| 19 | regulation of activated T cell proliferation (GO:0046006) | 4.88267752 |
| 20 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.85231095 |
| 21 | positive regulation of defense response to virus by host (GO:0002230) | 4.76064400 |
| 22 | ribosomal small subunit biogenesis (GO:0042274) | 4.70144814 |
| 23 | positive regulation of fibroblast migration (GO:0010763) | 4.62978134 |
| 24 | oxaloacetate metabolic process (GO:0006107) | 4.60826029 |
| 25 | morphogenesis of an endothelium (GO:0003159) | 4.54703158 |
| 26 | endothelial tube morphogenesis (GO:0061154) | 4.54703158 |
| 27 | regulation of mesoderm development (GO:2000380) | 4.51853244 |
| 28 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 4.50712530 |
| 29 | regulation of endothelial cell chemotaxis (GO:2001026) | 4.49201757 |
| 30 | L-fucose catabolic process (GO:0042355) | 4.48403776 |
| 31 | fucose catabolic process (GO:0019317) | 4.48403776 |
| 32 | L-fucose metabolic process (GO:0042354) | 4.48403776 |
| 33 | viral transcription (GO:0019083) | 4.48172145 |
| 34 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.36351523 |
| 35 | cardiac ventricle formation (GO:0003211) | 4.36006593 |
| 36 | growth hormone receptor signaling pathway (GO:0060396) | 4.35013961 |
| 37 | translational termination (GO:0006415) | 4.26693770 |
| 38 | nucleoside transmembrane transport (GO:1901642) | 4.26127527 |
| 39 | magnesium ion transport (GO:0015693) | 4.21168589 |
| 40 | opsonization (GO:0008228) | 4.19783701 |
| 41 | cardiac chamber formation (GO:0003207) | 4.02910703 |
| 42 | cellular response to growth hormone stimulus (GO:0071378) | 3.92437340 |
| 43 | behavioral response to nicotine (GO:0035095) | 3.87571101 |
| 44 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.83334881 |
| 45 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.75403740 |
| 46 | regulation of histone H3-K27 methylation (GO:0061085) | 3.75157871 |
| 47 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.73787831 |
| 48 | maturation of SSU-rRNA (GO:0030490) | 3.73439863 |
| 49 | cytidine deamination (GO:0009972) | 3.66364037 |
| 50 | cytidine metabolic process (GO:0046087) | 3.66364037 |
| 51 | cytidine catabolic process (GO:0006216) | 3.66364037 |
| 52 | negative regulation of cell fate commitment (GO:0010454) | 3.63894978 |
| 53 | positive regulation of macrophage cytokine production (GO:0060907) | 3.61923614 |
| 54 | specification of organ identity (GO:0010092) | 3.60778721 |
| 55 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 3.60424705 |
| 56 | male genitalia development (GO:0030539) | 3.56773706 |
| 57 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.56230989 |
| 58 | C4-dicarboxylate transport (GO:0015740) | 3.53892178 |
| 59 | regulation of chronic inflammatory response (GO:0002676) | 3.53559401 |
| 60 | regulation of cell fate commitment (GO:0010453) | 3.51924064 |
| 61 | regulation of interleukin-17 production (GO:0032660) | 3.51661855 |
| 62 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.45860372 |
| 63 | translational elongation (GO:0006414) | 3.45826372 |
| 64 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.42149742 |
| 65 | signal transduction involved in regulation of gene expression (GO:0023019) | 3.40406596 |
| 66 | negative regulation of interleukin-10 production (GO:0032693) | 3.38383525 |
| 67 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.34974658 |
| 68 | sleep (GO:0030431) | 3.34119711 |
| 69 | glycosphingolipid biosynthetic process (GO:0006688) | 3.29122884 |
| 70 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.27879084 |
| 71 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.24330287 |
| 72 | cellular protein complex disassembly (GO:0043624) | 3.21936666 |
| 73 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.21139363 |
| 74 | cotranslational protein targeting to membrane (GO:0006613) | 3.19383014 |
| 75 | viral life cycle (GO:0019058) | 3.17723836 |
| 76 | positive regulation of natural killer cell activation (GO:0032816) | 3.16500226 |
| 77 | positive regulation of T cell apoptotic process (GO:0070234) | 3.14735502 |
| 78 | regulation of histone deacetylation (GO:0031063) | 3.14707747 |
| 79 | protein targeting to ER (GO:0045047) | 3.14427165 |
| 80 | reactive oxygen species biosynthetic process (GO:1903409) | 3.13903872 |
| 81 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.13404078 |
| 82 | cellular response to prostaglandin stimulus (GO:0071379) | 3.13145523 |
| 83 | primary amino compound metabolic process (GO:1901160) | 3.08397620 |
| 84 | necroptotic process (GO:0070266) | 3.06112077 |
| 85 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.04892159 |
| 86 | regulation of cell fate specification (GO:0042659) | 3.04680357 |
| 87 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.03447184 |
| 88 | positive regulation of osteoclast differentiation (GO:0045672) | 3.02258033 |
| 89 | macrophage chemotaxis (GO:0048246) | 3.02078892 |
| 90 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.99482465 |
| 91 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.97222489 |
| 92 | ganglioside metabolic process (GO:0001573) | 2.97124615 |
| 93 | positive regulation of DNA biosynthetic process (GO:2000573) | 2.93399263 |
| 94 | positive regulation of tissue remodeling (GO:0034105) | 2.93324730 |
| 95 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.89236912 |
| 96 | protein localization to endoplasmic reticulum (GO:0070972) | 2.87063887 |
| 97 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.81863106 |
| 98 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.81863106 |
| 99 | cullin deneddylation (GO:0010388) | 11.0807169 |
| 100 | protein deneddylation (GO:0000338) | 10.6075545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 7.85286921 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.64934747 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.85039112 |
| 4 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 2.70179671 |
| 5 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.47426738 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.43764556 |
| 7 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.43043189 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.23980976 |
| 9 | TAF2_19829295_ChIP-Seq_ESCs_Human | 2.23489172 |
| 10 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 2.21086636 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.15194843 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.12269781 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.09662407 |
| 14 | RNF2_27304074_Chip-Seq_NSC_Mouse | 2.00100106 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.97006838 |
| 16 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.92566319 |
| 17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.90222723 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.89362828 |
| 19 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.86925977 |
| 20 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.82978538 |
| 21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.78554429 |
| 22 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.78387384 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.78209983 |
| 24 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.74581011 |
| 25 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.73276889 |
| 26 | TP53_16413492_ChIP-PET_HCT116_Human | 1.67881181 |
| 27 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.67735971 |
| 28 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.67735971 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.65523390 |
| 30 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.63375869 |
| 31 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.59609198 |
| 32 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.57083752 |
| 33 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.53167939 |
| 34 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.53124084 |
| 35 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.52909105 |
| 36 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.51793017 |
| 37 | SA1_27219007_Chip-Seq_Bcells_Human | 1.51363585 |
| 38 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.48673322 |
| 39 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.46444709 |
| 40 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.45279474 |
| 41 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.39010941 |
| 42 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.38368557 |
| 43 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.36237548 |
| 44 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.34434416 |
| 45 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.34418298 |
| 46 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.34160724 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.30441866 |
| 48 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.29723742 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29136647 |
| 50 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.29058756 |
| 51 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.28978811 |
| 52 | VDR_22108803_ChIP-Seq_LS180_Human | 1.27723473 |
| 53 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.25213638 |
| 54 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.25168738 |
| 55 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25095957 |
| 56 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.24348846 |
| 57 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.23906675 |
| 58 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.22797897 |
| 59 | NCOR_22424771_ChIP-Seq_293T_Human | 1.22523654 |
| 60 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.21953504 |
| 61 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.20121217 |
| 62 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.20089415 |
| 63 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.19843891 |
| 64 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.19294445 |
| 65 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.18373094 |
| 66 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18149151 |
| 67 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.17098933 |
| 68 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.14811333 |
| 69 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.13508659 |
| 70 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.13508659 |
| 71 | ERA_21632823_ChIP-Seq_H3396_Human | 1.12034422 |
| 72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.11842174 |
| 73 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.10977976 |
| 74 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10738896 |
| 75 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.10618487 |
| 76 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.10237427 |
| 77 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.10162536 |
| 78 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.09469706 |
| 79 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09255611 |
| 80 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.09176521 |
| 81 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.09113524 |
| 82 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.07765482 |
| 83 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07690584 |
| 84 | EWS_26573619_Chip-Seq_HEK293_Human | 1.07370670 |
| 85 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06353309 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06284663 |
| 87 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05972774 |
| 88 | P300_19829295_ChIP-Seq_ESCs_Human | 1.05192636 |
| 89 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.04182679 |
| 90 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.01721136 |
| 91 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.01644925 |
| 92 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.00841397 |
| 93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00679096 |
| 94 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00180874 |
| 95 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.97573689 |
| 96 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.97562283 |
| 97 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.97468389 |
| 98 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95930224 |
| 99 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.94817913 |
| 100 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.94439657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002234_abnormal_pharynx_morphology | 5.51534357 |
| 2 | MP0008875_abnormal_xenobiotic_pharmacok | 4.35068064 |
| 3 | MP0003690_abnormal_glial_cell | 4.25556630 |
| 4 | MP0002876_abnormal_thyroid_physiology | 4.09243539 |
| 5 | MP0004130_abnormal_muscle_cell | 3.46312766 |
| 6 | MP0005360_urolithiasis | 3.37495663 |
| 7 | MP0001873_stomach_inflammation | 3.29080473 |
| 8 | MP0006082_CNS_inflammation | 3.17858675 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.92819533 |
| 10 | MP0005671_abnormal_response_to | 2.61488276 |
| 11 | MP0000678_abnormal_parathyroid_gland | 2.47030145 |
| 12 | MP0009785_altered_susceptibility_to | 1.97411122 |
| 13 | MP0000465_gastrointestinal_hemorrhage | 1.89334873 |
| 14 | MP0008872_abnormal_physiological_respon | 1.86999551 |
| 15 | MP0006292_abnormal_olfactory_placode | 1.84452809 |
| 16 | MP0003075_altered_response_to | 1.74727965 |
| 17 | MP0004510_myositis | 1.71393947 |
| 18 | MP0009765_abnormal_xenobiotic_induced | 1.57180458 |
| 19 | MP0003646_muscle_fatigue | 1.55038913 |
| 20 | MP0001800_abnormal_humoral_immune | 1.54411503 |
| 21 | MP0002160_abnormal_reproductive_system | 1.54144211 |
| 22 | MP0010386_abnormal_urinary_bladder | 1.51849189 |
| 23 | MP0009384_cardiac_valve_regurgitation | 1.43186745 |
| 24 | MP0000343_altered_response_to | 1.43162148 |
| 25 | MP0009046_muscle_twitch | 1.34808519 |
| 26 | MP0005025_abnormal_response_to | 1.33221901 |
| 27 | MP0001984_abnormal_olfaction | 1.29464838 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.29429439 |
| 29 | MP0003879_abnormal_hair_cell | 1.29085901 |
| 30 | MP0004264_abnormal_extraembryonic_tissu | 1.29021910 |
| 31 | MP0006072_abnormal_retinal_apoptosis | 1.28358318 |
| 32 | MP0001663_abnormal_digestive_system | 1.27430815 |
| 33 | MP0002837_dystrophic_cardiac_calcinosis | 1.27154779 |
| 34 | MP0003638_abnormal_response/metabolism_ | 1.19439308 |
| 35 | MP0005389_reproductive_system_phenotype | 1.17212988 |
| 36 | MP0002933_joint_inflammation | 1.17050102 |
| 37 | MP0005085_abnormal_gallbladder_physiolo | 1.15539021 |
| 38 | MP0002638_abnormal_pupillary_reflex | 1.14956497 |
| 39 | MP0003303_peritoneal_inflammation | 1.13913836 |
| 40 | MP0004885_abnormal_endolymph | 1.13228989 |
| 41 | MP0001765_abnormal_ion_homeostasis | 1.11571875 |
| 42 | MP0000230_abnormal_systemic_arterial | 1.10759047 |
| 43 | MP0008775_abnormal_heart_ventricle | 1.10095515 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.09966698 |
| 45 | MP0009780_abnormal_chondrocyte_physiolo | 1.08332266 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.07995720 |
| 47 | MP0005166_decreased_susceptibility_to | 1.05894342 |
| 48 | MP0003136_yellow_coat_color | 1.04641931 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.02281708 |
| 50 | MP0005645_abnormal_hypothalamus_physiol | 1.01852596 |
| 51 | MP0003436_decreased_susceptibility_to | 0.97995010 |
| 52 | MP0004142_abnormal_muscle_tone | 0.97909626 |
| 53 | MP0005636_abnormal_mineral_homeostasis | 0.96994004 |
| 54 | MP0002419_abnormal_innate_immunity | 0.94681229 |
| 55 | MP0002102_abnormal_ear_morphology | 0.94622401 |
| 56 | MP0005620_abnormal_muscle_contractility | 0.94264585 |
| 57 | MP0004145_abnormal_muscle_electrophysio | 0.93871388 |
| 58 | MP0005332_abnormal_amino_acid | 0.93479599 |
| 59 | MP0000049_abnormal_middle_ear | 0.93409532 |
| 60 | MP0002557_abnormal_social/conspecific_i | 0.92490887 |
| 61 | MP0002723_abnormal_immune_serum | 0.92468674 |
| 62 | MP0002733_abnormal_thermal_nociception | 0.91841363 |
| 63 | MP0002177_abnormal_outer_ear | 0.90701431 |
| 64 | MP0000631_abnormal_neuroendocrine_gland | 0.90459298 |
| 65 | MP0003567_abnormal_fetal_cardiomyocyte | 0.89049514 |
| 66 | MP0002148_abnormal_hypersensitivity_rea | 0.86964285 |
| 67 | MP0001790_abnormal_immune_system | 0.86360713 |
| 68 | MP0005387_immune_system_phenotype | 0.86360713 |
| 69 | MP0006276_abnormal_autonomic_nervous | 0.86219088 |
| 70 | MP0005164_abnormal_response_to | 0.85431617 |
| 71 | MP0005381_digestive/alimentary_phenotyp | 0.84184547 |
| 72 | MP0001501_abnormal_sleep_pattern | 0.84114885 |
| 73 | MP0003878_abnormal_ear_physiology | 0.82611936 |
| 74 | MP0005377_hearing/vestibular/ear_phenot | 0.82611936 |
| 75 | MP0001970_abnormal_pain_threshold | 0.81262936 |
| 76 | MP0002822_catalepsy | 0.80653882 |
| 77 | MP0009745_abnormal_behavioral_response | 0.80290311 |
| 78 | MP0005423_abnormal_somatic_nervous | 0.76479116 |
| 79 | MP0001986_abnormal_taste_sensitivity | 0.75514361 |
| 80 | MP0000604_amyloidosis | 0.75397043 |
| 81 | MP0005595_abnormal_vascular_smooth | 0.75306247 |
| 82 | MP0008004_abnormal_stomach_pH | 0.74550554 |
| 83 | MP0009764_decreased_sensitivity_to | 0.73801270 |
| 84 | MP0002420_abnormal_adaptive_immunity | 0.73340391 |
| 85 | MP0001819_abnormal_immune_cell | 0.71190108 |
| 86 | MP0001905_abnormal_dopamine_level | 0.70611813 |
| 87 | MP0002572_abnormal_emotion/affect_behav | 0.70385417 |
| 88 | MP0010155_abnormal_intestine_physiology | 0.70120211 |
| 89 | MP0003252_abnormal_bile_duct | 0.70046804 |
| 90 | MP0004742_abnormal_vestibular_system | 0.70010604 |
| 91 | MP0002972_abnormal_cardiac_muscle | 0.69100505 |
| 92 | MP0000538_abnormal_urinary_bladder | 0.68753634 |
| 93 | MP0002736_abnormal_nociception_after | 0.68554351 |
| 94 | MP0004019_abnormal_vitamin_homeostasis | 0.68356171 |
| 95 | MP0002735_abnormal_chemical_nociception | 0.67831931 |
| 96 | MP0005464_abnormal_platelet_physiology | 0.66377793 |
| 97 | MP0001835_abnormal_antigen_presentation | 0.66302468 |
| 98 | MP0000579_abnormal_nail_morphology | 0.66299321 |
| 99 | MP0001968_abnormal_touch/_nociception | 0.65855343 |
| 100 | MP0003880_abnormal_central_pattern | 0.65588511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune thrombocytopenia (HP:0001973) | 7.47029167 |
| 2 | Increased IgM level (HP:0003496) | 6.44450133 |
| 3 | Autoimmune hemolytic anemia (HP:0001890) | 6.40123599 |
| 4 | Enlarged epiphyses (HP:0010580) | 5.74901838 |
| 5 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.40990631 |
| 6 | Abnormality of the columella (HP:0009929) | 4.87452906 |
| 7 | Birth length less than 3rd percentile (HP:0003561) | 4.85598292 |
| 8 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.76543063 |
| 9 | Depressed nasal tip (HP:0000437) | 4.66734186 |
| 10 | Neonatal hypoglycemia (HP:0001998) | 4.51792131 |
| 11 | Lip pit (HP:0100267) | 4.31462023 |
| 12 | Hypochromic anemia (HP:0001931) | 4.19182531 |
| 13 | Anterior segment dysgenesis (HP:0007700) | 4.10048963 |
| 14 | Fragile nails (HP:0001808) | 4.09208858 |
| 15 | Chin dimple (HP:0010751) | 4.04049551 |
| 16 | Decreased subcutaneous fat (HP:0001002) | 4.02624026 |
| 17 | Eosinophilia (HP:0001880) | 3.85507028 |
| 18 | Epileptic encephalopathy (HP:0200134) | 3.69126913 |
| 19 | Agammaglobulinemia (HP:0004432) | 3.63467642 |
| 20 | Abnormality of T cell number (HP:0011839) | 3.63185610 |
| 21 | Global brain atrophy (HP:0002283) | 3.49536192 |
| 22 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.46812311 |
| 23 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.46812311 |
| 24 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.38974039 |
| 25 | Myotonia (HP:0002486) | 3.37404737 |
| 26 | Erythroderma (HP:0001019) | 3.25178445 |
| 27 | Gastrointestinal stroma tumor (HP:0100723) | 3.23738568 |
| 28 | Thyroid-stimulating hormone excess (HP:0002925) | 3.15819245 |
| 29 | Sparse lateral eyebrow (HP:0005338) | 3.11889802 |
| 30 | Hemiplegia (HP:0002301) | 3.04132176 |
| 31 | Abnormality of eosinophils (HP:0001879) | 2.93739765 |
| 32 | Vasculitis (HP:0002633) | 2.91923464 |
| 33 | Abnormality of subcutaneous fat tissue (HP:0001001) | 2.88074832 |
| 34 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.86768340 |
| 35 | Granulocytopenia (HP:0001913) | 2.86115052 |
| 36 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.77136425 |
| 37 | Cortical visual impairment (HP:0100704) | 2.77003883 |
| 38 | Premature skin wrinkling (HP:0100678) | 2.76646488 |
| 39 | Conjugated hyperbilirubinemia (HP:0002908) | 2.73999191 |
| 40 | Abnormality of the neuromuscular junction (HP:0003398) | 2.73955859 |
| 41 | Fatigable weakness (HP:0003473) | 2.73955859 |
| 42 | Abnormality of the fingertips (HP:0001211) | 2.66458132 |
| 43 | Leukocytosis (HP:0001974) | 2.64875098 |
| 44 | Hyperthyroidism (HP:0000836) | 2.64804902 |
| 45 | Glucose intolerance (HP:0000833) | 2.56602531 |
| 46 | Long palpebral fissure (HP:0000637) | 2.55948269 |
| 47 | Brittle hair (HP:0002299) | 2.51924229 |
| 48 | Status epilepticus (HP:0002133) | 2.50586545 |
| 49 | Hypoplasia of the iris (HP:0007676) | 2.46667693 |
| 50 | Cupped ear (HP:0000378) | 2.33739133 |
| 51 | Orchitis (HP:0100796) | 2.30839908 |
| 52 | Abnormality of T cell physiology (HP:0011840) | 2.30247682 |
| 53 | Rectal prolapse (HP:0002035) | 2.28785437 |
| 54 | Hyperglycemia (HP:0003074) | 2.18293227 |
| 55 | IgG deficiency (HP:0004315) | 2.17658295 |
| 56 | Macrocytic anemia (HP:0001972) | 2.17654661 |
| 57 | Hypergammaglobulinemia (HP:0010702) | 2.15542511 |
| 58 | Generalized tonic-clonic seizures (HP:0002069) | 2.14552819 |
| 59 | Delayed epiphyseal ossification (HP:0002663) | 2.12616297 |
| 60 | Neutropenia (HP:0001875) | 2.08218974 |
| 61 | Congenital stationary night blindness (HP:0007642) | 2.06702342 |
| 62 | Congenital sensorineural hearing impairment (HP:0008527) | 2.06346307 |
| 63 | Lower limb hyperreflexia (HP:0002395) | 2.06087865 |
| 64 | Urticaria (HP:0001025) | 2.06048449 |
| 65 | Medial flaring of the eyebrow (HP:0010747) | 2.02483654 |
| 66 | Lymphopenia (HP:0001888) | 1.99002825 |
| 67 | Abnormality of T cells (HP:0002843) | 1.96212841 |
| 68 | Pallor (HP:0000980) | 1.95304362 |
| 69 | Type 2 muscle fiber atrophy (HP:0003554) | 1.95211198 |
| 70 | Abnormality of macular pigmentation (HP:0008002) | 1.95163525 |
| 71 | Cutaneous finger syndactyly (HP:0010554) | 1.92846180 |
| 72 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.89537708 |
| 73 | Stomatitis (HP:0010280) | 1.88780979 |
| 74 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.86314786 |
| 75 | Abnormality of alanine metabolism (HP:0010916) | 1.86314786 |
| 76 | Hyperalaninemia (HP:0003348) | 1.86314786 |
| 77 | Absent speech (HP:0001344) | 1.83800395 |
| 78 | Myositis (HP:0100614) | 1.81896633 |
| 79 | Retrobulbar optic neuritis (HP:0100654) | 1.79308588 |
| 80 | Optic neuritis (HP:0100653) | 1.79308588 |
| 81 | Hypocalcemia (HP:0002901) | 1.74895327 |
| 82 | Oligodontia (HP:0000677) | 1.72323716 |
| 83 | Protruding ear (HP:0000411) | 1.72243592 |
| 84 | Emphysema (HP:0002097) | 1.72028992 |
| 85 | Irritability (HP:0000737) | 1.71164721 |
| 86 | Mediastinal lymphadenopathy (HP:0100721) | 1.70252595 |
| 87 | Meningitis (HP:0001287) | 1.68008696 |
| 88 | Mesomelia (HP:0003027) | 1.67264911 |
| 89 | Cutaneous syndactyly (HP:0012725) | 1.62536016 |
| 90 | Muscle fiber atrophy (HP:0100295) | 1.61082874 |
| 91 | Ectropion (HP:0000656) | 1.57682727 |
| 92 | Breast aplasia (HP:0100783) | 1.55857601 |
| 93 | Abnormality of the pupil (HP:0000615) | 1.54364235 |
| 94 | Abnormal glucose tolerance (HP:0001952) | 1.53059590 |
| 95 | Facial shape deformation (HP:0011334) | 1.51734524 |
| 96 | Potter facies (HP:0002009) | 1.51734524 |
| 97 | Abnormal albumin level (HP:0012116) | 1.51703244 |
| 98 | Hypoalbuminemia (HP:0003073) | 1.51703244 |
| 99 | Asplenia (HP:0001746) | 1.51595345 |
| 100 | Widely patent fontanelles and sutures (HP:0004492) | 1.50336625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 8.28864892 |
| 2 | PIK3CA | 7.01601119 |
| 3 | ERN1 | 3.59657803 |
| 4 | CDK19 | 3.28096331 |
| 5 | NUAK1 | 3.25107899 |
| 6 | VRK2 | 3.14310815 |
| 7 | PRKD2 | 2.88981385 |
| 8 | MAP3K13 | 2.47478472 |
| 9 | PRKCH | 2.42154097 |
| 10 | TESK2 | 2.26500997 |
| 11 | ADRBK2 | 2.17039347 |
| 12 | OXSR1 | 1.69588476 |
| 13 | GRK7 | 1.68560865 |
| 14 | MOS | 1.57736036 |
| 15 | CAMK1D | 1.44565115 |
| 16 | KIT | 1.42548868 |
| 17 | PRKCG | 1.42178946 |
| 18 | ADRBK1 | 1.41912658 |
| 19 | ICK | 1.37171068 |
| 20 | CAMKK2 | 1.31015680 |
| 21 | TESK1 | 1.25078116 |
| 22 | MAPK12 | 1.24285054 |
| 23 | RET | 1.16964055 |
| 24 | MAP3K6 | 1.16065671 |
| 25 | BMPR2 | 1.04219787 |
| 26 | MAP2K6 | 1.03489660 |
| 27 | VRK1 | 0.96299188 |
| 28 | MUSK | 0.88886313 |
| 29 | MAP4K2 | 0.88301725 |
| 30 | PRKD1 | 0.86961092 |
| 31 | JAK3 | 0.84014539 |
| 32 | GRK5 | 0.83343439 |
| 33 | LIMK1 | 0.83282607 |
| 34 | STK11 | 0.82934721 |
| 35 | TGFBR2 | 0.77799092 |
| 36 | PRKCE | 0.76770626 |
| 37 | PTK2 | 0.76419700 |
| 38 | ITK | 0.74696662 |
| 39 | TXK | 0.70323121 |
| 40 | INSRR | 0.67878575 |
| 41 | GRK6 | 0.67508634 |
| 42 | GRK1 | 0.67390167 |
| 43 | CAMK1G | 0.65757874 |
| 44 | WNK3 | 0.64350526 |
| 45 | ERBB2 | 0.60659399 |
| 46 | OBSCN | 0.58827635 |
| 47 | PRKCZ | 0.56994494 |
| 48 | MAP2K3 | 0.55164161 |
| 49 | PDK1 | 0.54976421 |
| 50 | IKBKB | 0.49807102 |
| 51 | LCK | 0.48994546 |
| 52 | TIE1 | 0.48840277 |
| 53 | UHMK1 | 0.47874646 |
| 54 | PDGFRB | 0.47763227 |
| 55 | PRKCI | 0.46564685 |
| 56 | FRK | 0.45907634 |
| 57 | STK10 | 0.45624529 |
| 58 | INSR | 0.42133975 |
| 59 | MAP3K9 | 0.42009748 |
| 60 | ARAF | 0.41554806 |
| 61 | SYK | 0.41119560 |
| 62 | BRAF | 0.41052442 |
| 63 | PRKACG | 0.40264834 |
| 64 | MAP2K4 | 0.39747109 |
| 65 | WNK4 | 0.38462937 |
| 66 | PAK3 | 0.38141179 |
| 67 | MATK | 0.37331662 |
| 68 | STK3 | 0.37197981 |
| 69 | PRKACA | 0.37136289 |
| 70 | PRKG1 | 0.36677725 |
| 71 | PRKCA | 0.36487886 |
| 72 | MARK3 | 0.35775206 |
| 73 | CHEK1 | 0.34042084 |
| 74 | NTRK2 | 0.33328485 |
| 75 | JAK2 | 0.33246989 |
| 76 | EPHA4 | 0.33009075 |
| 77 | PDPK1 | 0.32433459 |
| 78 | IGF1R | 0.31661887 |
| 79 | TEC | 0.31491355 |
| 80 | PRKAA1 | 0.31032870 |
| 81 | ZAK | 0.30588855 |
| 82 | PRKCD | 0.29317652 |
| 83 | PRKAA2 | 0.28969708 |
| 84 | MINK1 | 0.28465007 |
| 85 | CAMKK1 | 0.27357512 |
| 86 | PRKCB | 0.27077792 |
| 87 | MAPK15 | 0.26821165 |
| 88 | CAMK2A | 0.25592537 |
| 89 | CAMK1 | 0.25376631 |
| 90 | FYN | 0.24890088 |
| 91 | BTK | 0.23105230 |
| 92 | TYK2 | 0.22745269 |
| 93 | AKT2 | 0.22159114 |
| 94 | MAP2K2 | 0.22041668 |
| 95 | PRKCQ | 0.21780334 |
| 96 | MAP3K14 | 0.21676030 |
| 97 | EPHB2 | 0.21029186 |
| 98 | KDR | 0.18606045 |
| 99 | CSNK1D | 0.18036693 |
| 100 | CSNK2A2 | 0.17344527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 4.48770507 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.28537995 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.13921907 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.45920841 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.36684173 |
| 6 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.31721496 |
| 7 | African trypanosomiasis_Homo sapiens_hsa05143 | 3.25318429 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.10804884 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.69670401 |
| 10 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.52865805 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.97456450 |
| 12 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.88539197 |
| 13 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.86822674 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.84023326 |
| 15 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.78181005 |
| 16 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75748295 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.68972672 |
| 18 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.68292307 |
| 19 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.55854899 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.46646094 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.36545822 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.15260218 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.13813941 |
| 24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12096913 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.11042430 |
| 26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.10616098 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.00556628 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.97194173 |
| 29 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.97033375 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.93299825 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93294409 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 0.93264138 |
| 33 | Nicotine addiction_Homo sapiens_hsa05033 | 0.83522918 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.79075152 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78279176 |
| 36 | Prion diseases_Homo sapiens_hsa05020 | 0.77014044 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 0.76857687 |
| 38 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75987195 |
| 39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72054127 |
| 40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71930268 |
| 41 | Renin secretion_Homo sapiens_hsa04924 | 0.71021023 |
| 42 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70089318 |
| 43 | Phototransduction_Homo sapiens_hsa04744 | 0.69035927 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.68736633 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.67775961 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.67456532 |
| 47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66259225 |
| 48 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.65695862 |
| 49 | Morphine addiction_Homo sapiens_hsa05032 | 0.64223625 |
| 50 | Melanoma_Homo sapiens_hsa05218 | 0.63459136 |
| 51 | Olfactory transduction_Homo sapiens_hsa04740 | 0.63412288 |
| 52 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63400386 |
| 53 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62402177 |
| 54 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.59918364 |
| 55 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.59350538 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59162880 |
| 57 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.58943051 |
| 58 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.58726134 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.58146184 |
| 60 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57973494 |
| 61 | Taste transduction_Homo sapiens_hsa04742 | 0.57722271 |
| 62 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57622135 |
| 63 | Influenza A_Homo sapiens_hsa05164 | 0.57490911 |
| 64 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57456325 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.57290298 |
| 66 | Measles_Homo sapiens_hsa05162 | 0.56587606 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55039295 |
| 68 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.53168530 |
| 69 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.52695357 |
| 70 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.50891701 |
| 71 | GABAergic synapse_Homo sapiens_hsa04727 | 0.50646846 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.50643822 |
| 73 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50427959 |
| 74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49133779 |
| 75 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49004407 |
| 76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.46788250 |
| 77 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.45726674 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45640269 |
| 79 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.42655689 |
| 80 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42020443 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 0.41509831 |
| 82 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41279071 |
| 83 | Basal transcription factors_Homo sapiens_hsa03022 | 0.40727476 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38190640 |
| 85 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.37499073 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33313638 |
| 87 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.33171437 |
| 88 | Platelet activation_Homo sapiens_hsa04611 | 0.32612038 |
| 89 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.30960804 |
| 90 | Parkinsons disease_Homo sapiens_hsa05012 | 0.29007949 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.27675478 |
| 92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26472072 |
| 93 | Tuberculosis_Homo sapiens_hsa05152 | 0.24737021 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.24510122 |
| 95 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.24096824 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.23650880 |
| 97 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.22229837 |
| 98 | Leishmaniasis_Homo sapiens_hsa05140 | 0.21882703 |
| 99 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.20609987 |
| 100 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.19577380 |

